Is Pfizer Stock a Buy?
Pharmaceutical giant (NYSE: PFE) is trading near its lowest price in over a decade.
The company's revenue and profits ballooned during the pandemic on its COVID-19 vaccine and treatment. Then the balloon popped and the business contracted, sending investors running for the exits. Pfizer has become an interesting case of a well-known stock offering an outsized dividend yield.
Is this a classic yield trap -- an abnormally high yield with poor business fundamentals lurking beneath the surface? Or could it be a once-in-a-decade investment opportunity?
Source Fool.com
Pfizer Inc. Stock
€21.37
0.300%
With 14 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 27 € there is a positive potential of 26.37% for Pfizer Inc. compared to the current price of 21.37 €.
